Quality by design case study 1: Design of 5-fluorouracil loaded lipid nanoparticles by the W/O/W double emulsion - Solvent evaporation method

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Gulin AmasyaNilufer Tarimci

Abstract

With Quality by Design (QbD), a systematic approach involving design and development of all production processes to achieve the final product with a predetermined quality, you work within a design space that determines the critical formulation and process parameters. Verification of the quality of the final product is no longer necessary. In the current study, the QbD approach was used in the preparation of lipid nanoparticle formulations to improve skin penetration of 5-Fluorouracil, a widely-used compound for treating non-melanoma skin cancer. 5-Fluorouracil-loaded lipid nanoparticles were prepared by the W/O/W double emulsion - solvent evaporation method. Artificial neural network software was used to evaluate the data obtained from the lipid nanoparticle formulations, to establish the design space, and to optimize the formulations. Two different artificial neural network models were developed. The limit values of the design space of the inputs and outputs obtained by both models were found to be within the knowledge space. The optimal formulations recommended by the models were prepared and the critical quality attributes belonging to those formulations were assigned. The experimental results remained within the design spac...Continue Reading

References

Oct 31, 1998·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·J BourquinH Leuenberger
Mar 4, 2000·International Journal of Pharmaceutics·V Jenning, S Gohla
May 18, 2000·Journal of Pharmaceutical and Biomedical Analysis·S Agatonovic-Kustrin, R Beresford
Apr 20, 2001·Advanced Drug Delivery Reviews·W Mehnert, K Mäder
Mar 7, 2002·Critical Reviews in Oncology/hematology·Janine G EinspahrDavid S Alberts
Apr 23, 2002·The British Journal of Dermatology·Thomas L Diepgen, V Mahler
May 14, 2003·Drug Development and Industrial Pharmacy·Pradeep M Sathe, Jurgen Venitz
Jul 11, 2003·Biomaterials·Béatrice HeurtaultJean-Pierre Benoit
Sep 5, 2003·Advanced Drug Delivery Reviews·Yichun SunAtul J Shukla
Dec 6, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Huabing ChenXiangliang Yang
Jun 5, 2007·Advanced Drug Delivery Reviews·Monika Schäfer-KortingHans-Christian Korting
Jan 15, 2008·International Journal of Pharmaceutics·Donatella PaolinoMassimo Fresta
Jun 26, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jia-You FangYu-Han Su
Nov 11, 2008·International Journal of Pharmaceutics·Jana PardeikeRainer H Müller
Feb 3, 2009·Colloids and Surfaces. B, Biointerfaces·Hong YuanFu-Qiang Hu
May 12, 2009·International Journal of Pharmaceutics·Qingzhi LvGuangxi Zhai
Dec 30, 2009·International Journal of Pharmaceutics·Ziyaur RahmanMansoor A Khan
May 13, 2010·Chemical & Pharmaceutical Bulletin·Sanjay SinghSubhashis Chakraborty
Jan 27, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Rainer H MüllerCornelia M Keck
Jul 13, 2011·AAPS PharmSciTech·Ulya BadıllıNilüfer Tarımcı
Apr 11, 2012·International Journal of Pharmaceutics·Guo Chen-yuZhai Guang-xi
Jun 12, 2012·International Journal of Pharmaceutics·Xiaoming XuDiane J Burgess
Aug 7, 2013·Journal of Pharmaceutical Sciences·Firat YerlikayaYilmaz Capan
Aug 15, 2013·Journal of Liposome Research·Abhijeet P PandeyPrashant K Deshmukh
Jun 20, 2014·Colloids and Surfaces. B, Biointerfaces·Bhupender SinghSanjay Singh
Jul 14, 2014·Colloids and Surfaces. B, Biointerfaces·Amit K JainGovind P Agrawal
Aug 8, 2014·BioMed Research International·Chiara DianzaniGiuseppina Barrera
Oct 15, 2014·Acta Pharmaceutica Sinica. B·Youssef W NaguibZhengrong Cui
Oct 1, 2011·Drug Delivery and Translational Research·Sanyog JainNitin K Swarnakar
Jun 21, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Tasnuva HaqueMajella E Lane
Jul 3, 2015·International Journal of Pharmaceutics·Edina PallagiIldikó Csóka

❮ Previous
Next ❯

Citations

Jul 26, 2018·Expert Opinion on Drug Delivery·Vijay MishraAnshuman Shukla
Aug 15, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·M Clara Gonçalves
Nov 18, 2018·Current Medicinal Chemistry·Erzsébet CsányiSzilvia Berkó
Nov 4, 2017·Drug Development and Industrial Pharmacy·Bianca SylvesterIoan Tomuţă
Feb 10, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Priscilla Kolibea ManteNewman Osafo
Jan 31, 2021·Annales pharmaceutiques françaises·R Reddy Hv, S Bhattacharyya
May 22, 2021·Advanced Drug Delivery Reviews·Pauric BanniganChristine Allen
Mar 3, 2020·Advanced Drug Delivery Reviews·Livia Neves Borgheti-CardosoMaria Vitória Lopes Badra Bentley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.